Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burdach

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Evaluation of neutropenia with a maturation stage-specific chemorecruitinS E Burdach, J H Wissler, K G Evers, et al.
European Journal of Pediatrics|February 9, 1999
Cure of latex allergy by bone marrow transplantationV Wahn, H J Laws, C P Bode, et al.
Klinische Padiatrie|January 1, 1983
[Pre- and retrorenal neuroblastoma without kidney displacement]S E Burdach, J A Bliesener, K G Evers, et al.
Experimental Hematology|October 1, 1994
Induction of two distinct natural killer-cell populations, activated T cells and antineoplastic cytokines, by interleukin-2 therapy in children with solid tumorsD Dilloo, H J Laws, H Hanenberg, et al.
Cancer|August 1, 1995
Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized studyS E Burdach, M Müschenich, W Josephs, et al.
Medical and Pediatric Oncology|July 29, 1998
Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancyB C Engel, H J Laws, B Buttlies, et al.
The Journal of Experimental Medicine|April 1, 1995
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokineU von Freeden-Jeffry, P Vieira, L A Lucian, et al.
Klinische Padiatrie|July 1, 1997
Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patientsB C Engel, H J Laws, U Dirksen, et al.
Bone Marrow Transplantation|January 1, 1992
Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiencyD Dilloo, H Hanenberg, E M Schneider, et al.
Journal of Neurosurgery|February 5, 2000
Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administrationR J Packer, C Raffel, J G Villablanca, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Evaluation of neutropenia with a maturation stage-specific chemorecruitinS E Burdach, J H Wissler, K G Evers, et al.
European Journal of Pediatrics|February 9, 1999
Cure of latex allergy by bone marrow transplantationV Wahn, H J Laws, C P Bode, et al.
Klinische Padiatrie|January 1, 1983
[Pre- and retrorenal neuroblastoma without kidney displacement]S E Burdach, J A Bliesener, K G Evers, et al.
Experimental Hematology|October 1, 1994
Induction of two distinct natural killer-cell populations, activated T cells and antineoplastic cytokines, by interleukin-2 therapy in children with solid tumorsD Dilloo, H J Laws, H Hanenberg, et al.
Cancer|August 1, 1995
Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized studyS E Burdach, M Müschenich, W Josephs, et al.
Medical and Pediatric Oncology|July 29, 1998
Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancyB C Engel, H J Laws, B Buttlies, et al.
The Journal of Experimental Medicine|April 1, 1995
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokineU von Freeden-Jeffry, P Vieira, L A Lucian, et al.
Klinische Padiatrie|July 1, 1997
Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patientsB C Engel, H J Laws, U Dirksen, et al.
Bone Marrow Transplantation|January 1, 1992
Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiencyD Dilloo, H Hanenberg, E M Schneider, et al.
Journal of Neurosurgery|February 5, 2000
Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administrationR J Packer, C Raffel, J G Villablanca, et al.
Pageof 3